Neurotrophin-3 (NT-3) as a Potential Biomarker of the Peripheral Nervous System Damage Following Breast Cancer Treatment

Damage to the peripheral nervous system (PNS) is a common complication of breast cancer (BC) treatment, with 60 to 80% of breast cancer survivors experiencing symptoms of PNS damage. In the current study, the levels of brain-derived neurotrophic factor (BDNF), galectin-3 (Gal-3), and neurotrophin-3...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonyan, Samvel, Pospelova, Maria, Krasnikova, Varvara, Fionik, Olga, Alekseeva, Tatyana, Samochernykh, Konstantin, Ivanova, Nataliya, Vavilova, Tatyana, Vasilieva, Elena, Makhanova, Albina, Nikolaeva, Aleksandra, Bukkieva, Tatyana, Combs, Stephanie, Shevtsov, Maxim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123681/
https://www.ncbi.nlm.nih.gov/pubmed/37092524
http://dx.doi.org/10.3390/pathophysiology30020010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123681/
https://www.ncbi.nlm.nih.gov/pubmed/37092524
http://dx.doi.org/10.3390/pathophysiology30020010

Ejemplares similares